<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00639782</url>
  </required_header>
  <id_info>
    <org_study_id>ONXSJM1</org_study_id>
    <nct_id>NCT00639782</nct_id>
  </id_info>
  <brief_title>Prospective Randomized On-X Versus SJM Evaluation Trial</brief_title>
  <acronym>PROSE</acronym>
  <official_title>Thromboembolic Related Complications in a Randomized Trial of Previous and Current Generation Mechanical Valve Prostheses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>On-X Life Technologies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>On-X Life Technologies, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesizes that rate of thromboembolic complications of the On-X prosthesis is
      reduced as compared to the SJM prosthesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a multi-centre, randomized trial that will sequentially enroll up to 500
      eligible patients in each group from up to 10 participating study centres internationally to
      test the hypothesis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2003</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Thromboembolic events either major or reversible</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Heart Valve Disease</condition>
  <arm_group>
    <arm_group_label>ONX</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>On-X heart Valve Replacement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SJM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SJM heart valve replacement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>On-X Heart valve replacement</intervention_name>
    <description>On-X Heart valve replacement</description>
    <arm_group_label>ONX</arm_group_label>
    <other_name>On-X Prosthetic Heart Valve</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SJM Heart valve replacement</intervention_name>
    <description>SJM Heart valve replacement</description>
    <arm_group_label>SJM</arm_group_label>
    <other_name>St. Jude Medical Prosthetic Heart Valve</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patient requires an isolated mitral or isolated aortic valve replacement.
             (Patients undergoing coronary artery bypass and / or concomitant repair of mitral or
             tricuspid valves are eligible.)

          2. The patient is a candidate for receipt of a mechanical heart valve.

          3. The patient (or legal guardian) has signed a study-specific informed consent form
             agreeing to the randomization, data collection and follow-up requirements.

          4. The patient can be having a re-operative procedure, so long as the previous prosthetic
             valve is explanted and the patient does not become a double valve implantation
             patient.

        Exclusion Criteria:

          1. The patient is not a candidate to receive a mechanical heart valve.

          2. The patient already has a prosthetic valve other than the valve(s) being replaced at
             this time.

          3. The patient requires a tricuspid valve replacement.

          4. The patient is enrolled in another investigative study or trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Jamieson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric Jamieson, MD</last_name>
    <phone>(604) 240-6300</phone>
    <email>eric.jamieson@vch.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alanna Dyck</last_name>
    <email>prosecoordinator@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Southern California Permanente Medical Group</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>91101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Kaiser Foundation Hospital</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Washington University - St Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Vancouver General Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Victoria Heart Institute</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8R 4R2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Jewish General Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3000 CA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A P Kappetein, MD</last_name>
      <phone>31 10 703 2150</phone>
      <email>a.kappetein@erasmusmc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Leisbeth Duininck</last_name>
      <phone>31 10 703 3993</phone>
      <email>e.duininck@erasmusmc.nl</email>
    </contact_backup>
    <investigator>
      <last_name>A P Kappetein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Bergen</name>
      <address>
        <city>Bergen</city>
        <zip>N-5021</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rune Haaverstad, MD</last_name>
      <email>rune.haaverstad@helse-bergen.no</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Geisner, MD</last_name>
      <email>thomas.geisner@helse-bergen.no</email>
    </contact_backup>
    <investigator>
      <last_name>Rune Haaverstad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Geisner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Gothenburg</city>
        <zip>SE41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Wiklund, MD</last_name>
      <phone>46 31 41 7991</phone>
    </contact>
    <investigator>
      <last_name>Lars Wiklund, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Sweden</country>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2008</study_first_submitted>
  <study_first_submitted_qc>March 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2008</study_first_posted>
  <last_update_submitted>September 24, 2017</last_update_submitted>
  <last_update_submitted_qc>September 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>thromboembolism</keyword>
  <keyword>mechanical heart valves</keyword>
  <keyword>randomized</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

